| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.02B | 16.13B | 13.47B | 12.85B | 11.30B | 9.63B |
| Gross Profit | 2.07B | 2.27B | 1.94B | 1.59B | 1.51B | 1.19B |
| EBITDA | 950.42M | 1.16B | 1.45B | 1.30B | 884.28M | 774.61M |
| Net Income | 415.31M | 566.39M | 535.37M | 481.07M | 136.13M | 123.73M |
Balance Sheet | ||||||
| Total Assets | 15.43B | 14.52B | 14.10B | 10.49B | 9.60B | 9.07B |
| Cash, Cash Equivalents and Short-Term Investments | 776.85M | 929.12M | 1.78B | 649.55M | 523.38M | 716.74M |
| Total Debt | 5.59B | 5.31B | 4.57B | 2.74B | 2.39B | 2.31B |
| Total Liabilities | 10.38B | 9.51B | 9.51B | 6.46B | 6.02B | 5.67B |
| Stockholders Equity | 4.65B | 4.60B | 4.20B | 3.82B | 3.39B | 3.24B |
Cash Flow | ||||||
| Free Cash Flow | 139.36M | -1.21B | 59.13M | 126.65M | 183.03M | 117.89M |
| Operating Cash Flow | 1.10B | 1.67M | 963.70M | 788.16M | 718.74M | 763.05M |
| Investing Cash Flow | -1.35B | -1.01B | -964.28M | -811.26M | -689.43M | -490.84M |
| Financing Cash Flow | 31.91M | 184.56M | 1.14B | 80.93M | -41.23M | -111.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$14.48B | 16.53 | 15.02% | 2.59% | 20.33% | 27.05% | |
76 Outperform | HK$2.29B | 5.45 | 22.34% | 5.52% | 18.32% | 14.06% | |
68 Neutral | HK$2.08B | 4.47 | 9.11% | 7.28% | 13.14% | -28.26% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | HK$28.23B | 49.95 | 32.21% | 0.19% | ― | ― | |
56 Neutral | HK$194.00M | 9.85 | 5.04% | 9.14% | 4.01% | ― | |
40 Underperform | HK$350.63M | -7.12 | -8.16% | ― | -0.84% | 42.31% |
Leoch International Technology Limited has released supplemental information regarding the emoluments of its chief executive officers for the fiscal years 2023 and 2024. The announcement highlights changes in leadership, with Mr. Chang Jianwei serving as CEO until December 2024, after which Mr. Wu Kouyue took over. This update does not affect other information in the annual reports, maintaining the company’s transparency and stability in its executive compensation practices.
The most recent analyst rating on (HK:0842) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Leoch International Technology Limited stock, see the HK:0842 Stock Forecast page.
Leoch International Technology Limited announced its interim results for the six months ending June 30, 2025, showing an 11.9% increase in turnover compared to the previous year. However, the company experienced a significant decline in gross profit and profit attributable to owners, with a 71.3% drop in profit for the period. The results indicate financial challenges despite increased revenue, impacting the company’s profitability and shareholder returns.
The most recent analyst rating on (HK:0842) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Leoch International Technology Limited stock, see the HK:0842 Stock Forecast page.
Leoch International Technology Limited announced that its board of directors will meet on August 29, 2025, to review and approve the unaudited interim results for the first half of 2025, and to discuss the potential payment of an interim dividend. Additionally, the company provided a supplemental detail regarding its 2024 annual report, noting the weighted average closing price of its shares before the exercise of share options was HK$1.51.
Leoch International Technology Limited has entered into a Master Purchase Agreement with Dr. Dong to secure a stable supply of production facilities, essential for its expanding operations. This agreement, effective from August 13, 2025, to December 31, 2027, is a strategic move to ensure competitive terms and meet the company’s growing production needs, highlighting its commitment to operational growth and stability.